| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.038 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |